Driehaus Capital Management LLC Revolution Medicines, Inc. Transaction History

Driehaus Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$25.17 - $35.05 $12,333 - $17,174	-490 Reduced 0.22%	218,153 $6.04 Million
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $159,705 - $212,625	7,875 Added 3.74%	218,643 $5.85 Million
Q1 2023 May 15, 2023	SELL	$20.76 - $30.09 $114,989 - $166,668	-5,539 Reduced 2.56%	210,768 $4.57 Million
Q4 2022 Feb 14, 2023	SELL	$17.68 - $25.53 $51,095 - $73,781	-2,890 Reduced 1.32%	216,307 $5.15 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $3.83 Million - $5.7 Million	219,197 New	219,197 $4.32 Million
Q2 2021 Aug 16, 2021	SELL	$29.0 - $47.44 $5.97 Million - $9.76 Million	-205,788 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$37.21 - $54.43 $7.66 Million - $11.2 Million	205,788 New	205,788 $9.44 Million

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.